Clinical Trials
4 trialsNCT00074282 2023-06-29
Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLL
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT01013961 2023-06-28
Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia
Eastern Cooperative Oncology Group
Phase 2 Terminated
NCT00006390 2023-06-22
Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT00800943 2008-12-03
CRC005
Chronic Lymphocytic Leukemia Research Consortium
Phase 2 Unknown